美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

科兴生物

6.47

0.0000

成交量：- -

成交额：- -

市值：3.89亿

市盈率：6.66

高：6.47

开：6.47

低：6.47

收：6.47

数据加载中...

总览公司新闻资讯公告

科兴生物巨额分红背后：股息率高达850%！股票停牌已超6年

“新冠疫苗之王”科兴生物，超400亿元天价分红！

科兴生物制药股份有限公司股票交易异常波动公告

科兴生物，核弹级分红来了！派发每股55美元的现金红利

科兴水痘疫苗获尼泊尔药品注册批件

Prime Success发表声明纽约州法院认可我们作为科兴生物股东的权利，包括我们在即将召开的特别股东大会上投票的权利

美国商业资讯

科兴1500万元转让全资子公司股权，克癀胶囊从委托代工转向自产

山东财经头条

SAIF Partners提交Sinovac Biotech 2025年特别股东大会最终委托材料并提名十位资深董事候选人进入董事会

美国商业资讯

单方面终止合作！产品降价太猛，逼退上市药企

维梧资本与科兴董事会二次“舆战”。

Prime Success致信Sinovac Biotech股东

美国商业资讯

科兴制药：科益医药拟减持不超3%公司股份

【未名医药：收到北京科兴分红款1.35亿元】未名医药公告，近日公司收到参股公司北京科兴生物制品有限公司分红款项人民币1.35亿元。根据北京科兴董事会决议，按照各位股东在北京科兴注册资本中的出资比例对截至2024年12月31日累计可分配利润中的部分利润进行分配。公司持有北京科兴26.91%股权，可获得现金分红款人民币1.35亿元。截止本公告披露日，公司已收到上述全部现金分红款项。

科兴生物：股权争夺与审计风波 8亿美元股息

科兴新董事会回应维梧资本“炮轰”

北京科兴生物制品有限公司中标包头海关综合技术服务中心供货合同

新事 | 科兴生物被起诉

【通化东宝利拉鲁肽注射液获哥伦比亚GMP证书】近日，通化东宝与合作伙伴科兴生物制药股份有限公司携手的出海产品—利拉鲁肽注射液，正式获得哥伦比亚国家食品药品监督管理局颁发的GMP证书，为后续该产品在哥伦比亚的获批上市，以及拉美其他国家的市场准入打下坚实基础。利拉鲁肽注射液作为GLP-1受体激动剂，凭借其降糖、减重及心血管保护的多重疗效，已成为全球糖尿病治疗的一线药物，受到患者的广泛认可。

【科兴独家中标智利流感疫苗项目首批疫苗将于明日发往智利】SINOVAC科兴中标智利项目新闻发布会上，科兴副总裁、国际业务负责人孟伟宁介绍，1月10号，SINOVAC科兴旗下北京科兴生物制品有限公司生产的三价流感疫苗安尔来福®独家中标了智利政府2025年年度流感疫苗的全球招标，首批疫苗将于1月15日发往智利。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/SVA/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SVA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SVA\",,,,,undefined,":{"symbol":"SVA","market":"US","secType":"STK","nameCN":"科兴生物","latestPrice":6.47,"timestamp":1751562000000,"preClose":6.47,"halted":3,"volume":0,"delay":0,"floatShares":31169000,"shares":60060702,"eps":0.971025,"marketStatus":"停牌","change":0,"latestTime":"07-03 13:00:00 EDT","open":6.47,"high":6.47,"low":6.47,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.971025,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1751875200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1102482000000,"exchange":"NASDAQ","adjPreClose":6.47,"dividendRate":8.500773,"volumeRatio":0.9692647502567138},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SVA\",,,,,undefined,":{"symbol":"SVA","floatShares":31169000,"roa":"11.46%","roe":"25.15%","lyrEps":1.055174,"volumeRatio":0.9692647502567138,"shares":60060702,"dividePrice":55,"high":6.47,"amplitude":0,"preClose":6.47,"low":6.47,"week52Low":6.47,"pbRate":"0.52","week52High":6.47,"institutionHeld":0.0546,"latestPrice":6.47,"eps":0.971025,"divideRate":8.500773,"volume":0,"delay":0,"ttmEps":0.971025,"open":6.47,"prevYearClose":6.47,"prevWeekClose":6.47,"prevMonthClose":6.47,"prevQuarterClose":6.47,"fiveDayClose":6.47,"twentyDayClose":6.47,"sixtyDayClose":6.47},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SVA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2548395021","title":"科兴生物巨额分红背后：股息率高达850%！股票停牌已超6年","url":"https://stock-news.laohu8.com/highlight/detail?id=2548395021","media":"时代周报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548395021?lang=zh_cn&edition=fundamental","pubTime":"2025-07-04 19:07","pubTimestamp":1751627277,"startTime":"0","endTime":"0","summary":"近日，美股上市公司科兴生物因将派发巨额现金分红而引发关注。今年6月中旬，停牌6年多的科兴生物公告，将于7月初向全体股东进行每股55美元的特别股息现金分红。目前，按照停牌前的股价6.47美元/股，该笔分红相当于科兴生物股价的8.5倍，股息率高达850%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202507043448736060.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2548943813","title":"“新冠疫苗之王”科兴生物，超400亿元天价分红！","url":"https://stock-news.laohu8.com/highlight/detail?id=2548943813","media":"IVD资讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548943813?lang=zh_cn&edition=fundamental","pubTime":"2025-07-04 18:37","pubTimestamp":1751625452,"startTime":"0","endTime":"0","summary":"在新冠疫情之前，科兴生物的甲肝疫苗和EV71疫苗在中国及部分发展中国家占据一定市场份额，2019年公司归母净利润只有4492万美元。凭借新冠疫苗需求，2021年科兴生物营业总收入达193.75亿美元，同比增长3694%，其中大部分由新冠疫苗贡献，归母净利润84.67亿美元，同比增长7572%。不过早在2019年2月，科兴生物就因内部治理纠纷主动申请停牌，其股价被冻结在6.47美元的历史价位。紧接着，维梧资本又公开称起诉科兴生物董事会违法行为。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704194856a436e874&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704194856a436e874&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2548382733","title":"科兴生物制药股份有限公司股票交易异常波动公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2548382733","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548382733?lang=zh_cn&edition=fundamental","pubTime":"2025-07-04 03:38","pubTimestamp":1751571525,"startTime":"0","endTime":"0","summary":"重要内容提示：科兴生物制药股份有限公司股票连续三个交易日内收盘价格涨幅偏离值累计超过30%，属于股票交易异常波动。经公司核实，股价异常波动期间，公司控股股东及实际控制人、监事及其他董事、高级管理人员在公司本次股票交易异常波动期间未买卖公司股票。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507040346449798f916&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507040346449798f916&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2547031254","title":"科兴生物，核弹级分红来了！派发每股55美元的现金红利","url":"https://stock-news.laohu8.com/highlight/detail?id=2547031254","media":"MBA同DBA","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547031254?lang=zh_cn&edition=fundamental","pubTime":"2025-06-29 21:02","pubTimestamp":1751202174,"startTime":"0","endTime":"0","summary":"最近一场“核弹”级分红引发市场关注，科兴生物宣布将向股东派发每股55美元的现金红利。按照7月即将支付的每股55.00美元的特别现金股息，结合2019年2月科兴生物停牌前的6.47美元股价计算，股息率高达850%。不过早在2019年2月，科兴生物就因内部治理纠纷主动申请停牌，其股价自此被冻结在6.47美元的历史价位。紧接着，维梧资本又公开称起诉科兴生物董事会违法行为。股东也正敦促尽快发放每股55美元的股息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250629210834a724153c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250629210834a724153c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2545418942","title":"科兴水痘疫苗获尼泊尔药品注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2545418942","media":"DoNews","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545418942?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 17:33","pubTimestamp":1750671182,"startTime":"0","endTime":"0","summary":"科兴控股生物技术有限公司宣布，其自主研发的水痘减毒活疫苗已获得尼泊尔药品监督管理局颁发的药品注册批件。这是该疫苗首次在海外获得注册批准，标志着科兴水痘疫苗进入国际市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623173957978b13d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623173957978b13d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2545530814","title":"Prime Success发表声明纽约州法院认可我们作为科兴生物股东的权利，包括我们在即将召开的特别股东大会上投票的权利","url":"https://stock-news.laohu8.com/highlight/detail?id=2545530814","media":"美国商业资讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545530814?lang=zh_cn&edition=fundamental","pubTime":"2025-06-22 19:55","pubTimestamp":1750593300,"startTime":"0","endTime":"0","summary":"1Globe领导的激进董事会为误导股东的判断公然歪曲纽约法院的裁定，并蓄意隐瞒安提瓜法官上周五拒绝了其立即阻止Prime Success行使投票权的企图-- Prime Success L.P.作为持有科兴生物8%流通股的重要股东，今日就美国纽约州南区联邦地区法院于2025年6月20日（星期五）作出的裁定结果作出回应。关于Prime Success, L.P.Prime Success 是由 Advantech Capital为投资科兴及科兴中维而设立的投资主体。尚珹资本是一家成立于2016年的私募股权基金，聚焦中国创新驱动增长的投资机遇。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623035613a4b7b2a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623035613a4b7b2a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2544971781","title":"科兴1500万元转让全资子公司股权，克癀胶囊从委托代工转向自产","url":"https://stock-news.laohu8.com/highlight/detail?id=2544971781","media":"山东财经头条","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544971781?lang=zh_cn&edition=fundamental","pubTime":"2025-06-18 19:21","pubTimestamp":1750245694,"startTime":"0","endTime":"0","summary":"对于转让的原因，科兴生物方面表示，此前，科兴生物委托同安医药开展克癀胶囊的生产，现在，该公司已经独立掌握该药品的生产技术。此次交易完成后，科兴生物不再持有同安医药股权。不过，今年前三个月，科兴制药营收再次出现下跌情况，实现营业收入3.54亿元，同比下降1.97%；净利润方面态势良好，实现2485.11万元，同比增长116.32%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618192756a7106ab9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618192756a7106ab9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2544903238","title":"SAIF Partners提交Sinovac Biotech 2025年特别股东大会最终委托材料并提名十位资深董事候选人进入董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=2544903238","media":"美国商业资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544903238?lang=zh_cn&edition=fundamental","pubTime":"2025-06-18 13:57","pubTimestamp":1750226220,"startTime":"0","endTime":"0","summary":"SAIF Partners实益拥有约15%的已发行普通股。SAIF Partners已明确其董事候选人当选后的三大优先事项：追加股息分配、恢复普通股交易以及解决股东纠纷。其他信息和查找地点本函件可被视为有关SAIF Partners向Sinovac董事会提名十名董事候选人的邀约材料。在此征集过程中，SAIF Partners向Sinovac股东邮寄了与Sinovac董事会董事选举有关的特别会议的最终委托声明和委托书。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618215808a4b0a9b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618215808a4b0a9b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2544987176","title":"单方面终止合作！产品降价太猛，逼退上市药企","url":"https://stock-news.laohu8.com/highlight/detail?id=2544987176","media":"健识局","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544987176?lang=zh_cn&edition=fundamental","pubTime":"2025-06-17 09:20","pubTimestamp":1750123222,"startTime":"0","endTime":"0","summary":"6月15日，三叶草生物公告：已向国光生物发出通知终止四价流感疫苗的合作。国光生物是一家中国台湾的疫苗企业，生产的四价流感疫苗2022年1月在中国大陆获批上市。去年国药集团打响四价流感疫苗降价的第一枪，厮杀正式开始了。2024年，国药集团将四价流感疫苗降价30%至88元一支，首次破了百元大关。今年6月13日，赛诺菲率先恢复了四价流感疫苗在中国大陆的销售。2024年，华兰疫苗、金迪克营收分别下滑53%和40%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617092355a70d2e5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617092355a70d2e5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVA","02197"],"gpt_icon":0},{"id":"2543656096","title":"维梧资本与科兴董事会二次“舆战”。","url":"https://stock-news.laohu8.com/highlight/detail?id=2543656096","media":"医药财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543656096?lang=zh_cn&edition=fundamental","pubTime":"2025-06-14 08:07","pubTimestamp":1749859679,"startTime":"0","endTime":"0","summary":"董事会将最近的事件误导性地描述为仅与维梧之间的纠纷，但问题的本身完全来自于科兴的董事会，并不来自维梧。该等辞职亦使科兴的管理层公开表示担忧，认为当前董事会的行为已经扰乱了科兴的合规运营和治理。自2018年7月的首次投资以来，维梧持有公司大约8%的股份，且在六人董事会中只有一名代表。董事会谎称维梧控制了前董事会并导致公司在纳斯达克停牌。董事会声称维梧意图“双重获利”亦是完全错误并恶意诋毁维梧的言论。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614081438a4a8613f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614081438a4a8613f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2543545236","title":"Prime Success致信Sinovac Biotech股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2543545236","media":"美国商业资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543545236?lang=zh_cn&edition=fundamental","pubTime":"2025-06-12 16:00","pubTimestamp":1749715200,"startTime":"0","endTime":"0","summary":"Prime Success目前持有公司约8%的流通股。Prime Success在公开信中阐述了Sinovac董事会进行改革的必要性，并列出了支持选举SAIF Partners IV L.P.提名董事候选人的关键理由。与Prime Success的上述承诺举措完全不同，Sinovac董事会现任成员：采取的行动导致并延长了2019年公司股票在NASDAQ停牌，这极大损害了Sinovac的发展。Prime Success坚信，支持SAIF提名的董事人选对Sinovac的未来发展至关重要，并呼吁全体股东在2025年7月8日特别股东大会投票前，务必审阅SAIF提供的委托材料。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613000112a4a58239&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613000112a4a58239&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PSQ","USAW.SI","TQQQ","SVA","TSYW.SI",".IXIC","QID","MNQmain","QLD","SQQQ","USJW.SI","NVIW.SI","NQmain"],"gpt_icon":1},{"id":"2540065123","title":"科兴制药：科益医药拟减持不超3%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2540065123","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540065123?lang=zh_cn&edition=fundamental","pubTime":"2025-06-04 20:09","pubTimestamp":1749038940,"startTime":"0","endTime":"0","summary":"6月4日晚间，科兴生物制药股份有限公司公告，截至本公告披露日，深圳科益医药控股有限公司（以下简称“科益医药”）直接持有公司131,778,347股，占公司总股本的比例为66.01%。科益医药本次拟通过集中竞价或大宗交易方式减持所持有的公司股份为不超过5,989,200 股，即不超过公司目前股份总数的3.00%。本次减持计划自公告披露之日起15个交易日后的3个月内（根据中国证券监督管理委员会及上海证券交易所规定禁止减持的期间除外）进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604201853a6fa40a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604201853a6fa40a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2535391646","title":"【未名医药：收到北京科兴分红款1.35亿元】未名医药公告，近日公司收到参股公司北京科兴生物制品有限公司分红款项人民币1.35亿元。根据北京科兴董事会决议，按照各位股东在北京科兴注册资本中的出资比例对截至2024年12月31日累计可分配利润中的部分利润进行分配。公司持有北京科兴26.91%股权，可获得现金分红款人民币1.35亿元。截止本公告披露日，公司已收到上述全部现金分红款项。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535391646","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535391646?lang=zh_cn&edition=fundamental","pubTime":"2025-05-16 19:48","pubTimestamp":1747396098,"startTime":"0","endTime":"0","summary":"未名医药公告，近日公司收到参股公司北京科兴生物制品有限公司分红款项人民币1.35亿元。根据北京科兴董事会决议，按照各位股东在北京科兴注册资本中的出资比例对截至2024年12月31日累计可分配利润中的部分利润进行分配。公司持有北京科兴26.91%股权，可获得现金分红款人民币1.35亿元。截止本公告披露日，公司已收到上述全部现金分红款项。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/16194850460076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0197","002581","BK0239","SVA","BK0077","BK4139","BK0046","BK0042"],"gpt_icon":0},{"id":"2531777680","title":"科兴生物：股权争夺与审计风波 8亿美元股息","url":"https://stock-news.laohu8.com/highlight/detail?id=2531777680","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531777680?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 14:37","pubTimestamp":1745995069,"startTime":"0","endTime":"0","summary":"【4 月 29 日，国内著名疫苗厂商科兴生物与维梧资本陷纷争】科兴生物称维梧资本此前言论为虚假指控，维梧集团正通过诉讼等方式试图阻止公司向股东支付特别股息。科兴生物指出所有普通股股东过去七年分文未得，而维梧集团已从科兴一家控股子公司获超 8 亿美元现金股息。科兴生物认为维梧集团行为动机为谋财，其主张与法院裁决相悖。科兴生物的股权争夺战可追溯至 2016 年。维梧资本 4 月 24 日称已对科兴生物发起诉讼，审计师辞职致科兴生物无法按期提交年度报告。4 月 29 日科兴生物称审计师辞职原因在于无法依赖此前财务状况陈述，公司已增添审计委员会财务专家。（责任编辑：张晓波 ）","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430144525a6ce69b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430144525a6ce69b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2531724393","title":"科兴新董事会回应维梧资本“炮轰”","url":"https://stock-news.laohu8.com/highlight/detail?id=2531724393","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531724393?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 11:41","pubTimestamp":1745984501,"startTime":"0","endTime":"0","summary":"简单理解，维梧资本代表的是科兴生物前董事会的利益，科兴生物当前的发文代表的是新董事会的决策。维梧资本目前将1 Globe视为“激进投资人”，认为“1 Globe及其控制下的董事会（会）进一步采取破坏性行动”。在科兴生物4月29日发文之前，4月24日，维梧资本在公众号发文称，公司已对科兴生物董事会发起诉讼。维梧资本认为，科兴生物董事会在1Globe及其盟友控制下，采取了诸多不负责任行为。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430114459a46d18a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430114459a46d18a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MNQmain","PSQ","QID","SQQQ","TSYW.SI","USAW.SI","NQmain","NVIW.SI","SVA","BK4007","ARTL",".IXIC","USJW.SI","QLD","TQQQ"],"gpt_icon":1},{"id":"2531001562","title":"北京科兴生物制品有限公司中标包头海关综合技术服务中心供货合同","url":"https://stock-news.laohu8.com/highlight/detail?id=2531001562","media":"iDoNews","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531001562?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 18:23","pubTimestamp":1745922182,"startTime":"0","endTime":"0","summary":"天眼查App显示，2025年04月28日，北京科兴生物制品有限公司中标包头海关综合技术服务中心的供货合同项目。该项目为海关总署2023-2024年出入境预防接种疫苗询价（重新招标）采购项目，合同金额为0.616000万元。合同主要信息显示，标的物为四价流感疫苗，规格型号为注射器包装，数量70个，单价88元。履约地点为内蒙古自治区包头市昆区少先路18号的包头海关综合技术服务中心，合同签订日期为2025年04月25日，公告类型为中标结果。免责声明：本文内容由开放的智能模型自动生成，仅供参考。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042918234894e760d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042918234894e760d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2530303180","title":"新事 | 科兴生物被起诉","url":"https://stock-news.laohu8.com/highlight/detail?id=2530303180","media":"健识局","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530303180?lang=zh_cn&edition=fundamental","pubTime":"2025-04-25 20:08","pubTimestamp":1745582937,"startTime":"0","endTime":"0","summary":"4月28日，维梧资本发布公告称：公司已对科兴控股生物技术有限公司的发起诉讼。双方争论的焦点是：科兴生物改变董事会人选之后，管理层作出一系列变化引发公司治理危机。为此，维梧资本在美国多地高等法院对科兴生物提起诉讼，要求法院下令禁止1 Globe进一步违反美国证券法，并强制其披露关于科兴生物的计划和相关方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425202525a466d40b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425202525a466d40b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2528376858","title":"【通化东宝利拉鲁肽注射液获哥伦比亚GMP证书】 近日，通化东宝与合作伙伴科兴生物制药股份有限公司携手的出海产品—利拉鲁肽注射液，正式获得哥伦比亚国家食品药品监督管理局颁发的GMP证书，为后续该产品在哥伦比亚的获批上市，以及拉美其他国家的市场准入打下坚实基础。利拉鲁肽注射液作为GLP-1受体激动剂，凭借其降糖、减重及心血管保护的多重疗效，已成为全球糖尿病治疗的一线药物，受到患者的广泛认可。","url":"https://stock-news.laohu8.com/highlight/detail?id=2528376858","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528376858?lang=zh_cn&edition=fundamental","pubTime":"2025-04-17 15:41","pubTimestamp":1744875705,"startTime":"0","endTime":"0","summary":"近日，通化东宝与合作伙伴科兴生物制药股份有限公司携手的出海产品—利拉鲁肽注射液，正式获得哥伦比亚国家食品药品监督管理局颁发的GMP证书，为后续该产品在哥伦比亚的获批上市，以及拉美其他国家的市场准入打下坚实基础。利拉鲁肽注射液作为GLP-1受体激动剂，凭借其降糖、减重及心血管保护的多重疗效，已成为全球糖尿病治疗的一线药物，受到患者的广泛认可。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/17154149616448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GLP","BK0188","SVA","01477","BK0196","BK1191","BK4139","BK0239","600867","BK4144","BK4590","BK1574"],"gpt_icon":0},{"id":"2503545080","title":"【科兴独家中标智利流感疫苗项目 首批疫苗将于明日发往智利】SINOVAC科兴中标智利项目新闻发布会上，科兴副总裁、国际业务负责人孟伟宁介绍，1月10号，SINOVAC科兴旗下北京科兴生物制品有限公司生产的三价流感疫苗安尔来福®独家中标了智利政府2025年年度流感疫苗的全球招标，首批疫苗将于1月15日发往智利。","url":"https://stock-news.laohu8.com/highlight/detail?id=2503545080","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503545080?lang=zh_cn&edition=fundamental","pubTime":"2025-01-14 16:59","pubTimestamp":1736845176,"startTime":"0","endTime":"0","summary":"SINOVAC科兴中标智利项目新闻发布会上，科兴副总裁、国际业务负责人孟伟宁介绍，1月10号，SINOVAC科兴旗下北京科兴生物制品有限公司生产的三价流感疫苗安尔来福®独家中标了智利政府2025年年度流感疫苗的全球招标，首批疫苗将于1月15日发往智利。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/14165947435781.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159646","BK4139","SVA"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SVA\",params:#limit:5,,,undefined,":[{"date":"2025-07-08","symbol":"SVA","amount":55,"announcedDate":"2025-04-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-23","defaultRemindTime":1751981400000,"name":"科兴生物","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-05-23","currency":"USD","dateTimestamp":1751947200000,"payDate":"2025-07-07"},{"market":"US","date":"2022-04-29","symbol":"SVA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1651204800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2021-12-31","symbol":"SVA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1640926800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2021-09-17","symbol":"SVA","fiscalQuarterEnding":"2021/06","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1631851200000,"reportTimeType":"post","actualEps":-0.05},{"market":"US","date":"2021-06-29","symbol":"SVA","fiscalQuarterEnding":"2021/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1624939200000,"reportTimeType":"","actualEps":-0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SVA\",market:\"US\",,,undefined,":[{"executeDate":"2025-07-08","recordDate":"2025-05-23","paymentDate":"2025-07-07","value":55,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SVA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SVA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SVA","date":"2021-09-21","current":5.82081,"percent":0.24257,"low":-100.201212,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"high":42.074882,"avg":0.136365,"sd":42.133061,"marketCap":642436987},"quantilePoints":[{"date":"2020-07-10","current":17.165727,"twenty":-59.560853,"median":24.863319,"eighty":133.776731,"marketCap":639903982},{"date":"2020-07-17","current":17.165727,"twenty":-59.560853,"median":24.709271,"eighty":133.776731,"marketCap":639903982},{"date":"2020-07-24","current":17.165727,"twenty":-59.560853,"median":24.647652,"eighty":133.776731,"marketCap":639903982},{"date":"2020-07-31","current":17.165727,"twenty":-59.560853,"median":24.616842,"eighty":133.776731,"marketCap":639903982},{"date":"2020-08-07","current":17.165727,"twenty":-59.560853,"median":24.555223,"eighty":133.776731,"marketCap":639903982},{"date":"2020-08-14","current":17.165727,"twenty":-59.560853,"median":24.431985,"eighty":132.906863,"marketCap":639903982},{"date":"2020-08-21","current":17.165727,"twenty":-59.560853,"median":24.370365,"eighty":42.074882,"marketCap":639903982},{"date":"2020-08-28","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":42.074882,"marketCap":639903982},{"date":"2020-09-04","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":42.074882,"marketCap":639903982},{"date":"2020-09-11","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":42.074882,"marketCap":639903982},{"date":"2020-09-18","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":42.074882,"marketCap":639903982},{"date":"2020-09-25","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":39.649553,"marketCap":639903982},{"date":"2020-10-02","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-10-09","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-10-16","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-10-23","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-10-30","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-11-06","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-11-13","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-11-20","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-11-27","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-12-04","current":29.948237,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-12-11","current":25.871431,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-12-18","current":25.871431,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-12-24","current":25.871431,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2020-12-31","current":25.871431,"twenty":-59.560853,"median":24.296893,"eighty":29.948237,"marketCap":639903982},{"date":"2021-01-08","current":25.871431,"twenty":-60.664761,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-01-15","current":25.871431,"twenty":-60.664761,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-01-22","current":25.871431,"twenty":-60.664761,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-01-29","current":25.871431,"twenty":-60.664761,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-02-05","current":25.871431,"twenty":-61.668314,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-02-12","current":25.871431,"twenty":-61.668314,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-02-19","current":25.871431,"twenty":-61.668314,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-02-26","current":25.871431,"twenty":-61.668314,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-03-05","current":25.871431,"twenty":-61.894113,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-03-12","current":25.871431,"twenty":-61.668314,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-03-19","current":25.871431,"twenty":-61.894113,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-03-26","current":25.871431,"twenty":-61.668314,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-04-01","current":25.871431,"twenty":-61.668314,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-04-09","current":25.871431,"twenty":-61.894113,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-04-16","current":25.871431,"twenty":-61.894113,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-04-23","current":5.79786,"twenty":-61.894113,"median":24.277937,"eighty":29.57901,"marketCap":639903982},{"date":"2021-04-30","current":5.82081,"twenty":-61.894113,"median":24.171596,"eighty":29.57901,"marketCap":642436987},{"date":"2021-05-07","current":5.82081,"twenty":-61.894113,"median":24.081398,"eighty":29.57901,"marketCap":642436987},{"date":"2021-05-14","current":5.82081,"twenty":-61.894113,"median":23.985687,"eighty":29.57901,"marketCap":642436987},{"date":"2021-05-21","current":5.82081,"twenty":-61.894113,"median":23.781276,"eighty":29.57901,"marketCap":642436987},{"date":"2021-05-28","current":5.82081,"twenty":-61.894113,"median":23.705864,"eighty":29.57901,"marketCap":642436987},{"date":"2021-06-04","current":5.82081,"twenty":-61.894113,"median":23.662388,"eighty":29.57901,"marketCap":642436987},{"date":"2021-06-11","current":5.82081,"twenty":-61.894113,"median":23.535556,"eighty":29.57901,"marketCap":642436987},{"date":"2021-06-18","current":5.82081,"twenty":-61.894113,"median":23.44385,"eighty":29.57901,"marketCap":642436987},{"date":"2021-06-25","current":5.82081,"twenty":-62.119913,"median":23.213593,"eighty":29.57901,"marketCap":642436987},{"date":"2021-07-02","current":5.82081,"twenty":-62.119913,"median":22.996932,"eighty":29.57901,"marketCap":642436987},{"date":"2021-07-09","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-07-16","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-07-23","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-07-30","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-08-06","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-08-13","current":5.82081,"twenty":-61.894113,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-08-20","current":5.82081,"twenty":-61.894113,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-08-27","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-09-03","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-09-10","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-09-17","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-09-24","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-10-01","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-10-08","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-10-15","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-10-22","current":5.82081,"twenty":-62.345712,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-10-29","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-11-05","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987},{"date":"2021-11-09","current":5.82081,"twenty":-62.119913,"median":22.039362,"eighty":29.57901,"marketCap":642436987}],"updateTime":1751791018891}}}